PHARMAGEN
PHARMAGEN, a leading pharmaceutical company headquartered in Pakistan (PK), has been at the forefront of the industry since its establishment in 1994. With a strong presence in both local and international markets, PHARMAGEN focuses on the development, manufacturing, and distribution of high-quality pharmaceutical products, including generic medicines and innovative therapies. Renowned for its commitment to quality and compliance, PHARMAGEN has achieved significant milestones, including various certifications and partnerships that enhance its market position. The company’s core offerings, which include a diverse range of formulations, are distinguished by their efficacy and safety, catering to the needs of healthcare professionals and patients alike. As a trusted name in the pharmaceutical sector, PHARMAGEN continues to contribute to the advancement of healthcare in Pakistan and beyond.
DitchCarbon Score
How does PHARMAGEN's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
PHARMAGEN's score of 0 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
PHARMAGEN's reported carbon emissions
PHARMAGEN, headquartered in PK, currently does not have available carbon emissions data for recent years, as no specific figures have been provided. Consequently, there are no reported emissions in terms of kg CO2e, nor are there any documented reduction targets or climate pledges. In the absence of concrete emissions data, it is essential to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate commitments. This often includes setting science-based targets for emissions reductions, enhancing energy efficiency, and investing in renewable energy sources. While PHARMAGEN has not disclosed specific initiatives or targets, the industry trend suggests a growing emphasis on reducing carbon footprints and addressing climate change. As the company moves forward, it may consider establishing measurable goals to align with global climate standards and contribute to a more sustainable future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
PHARMAGEN is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
